<?xml version='1.0' encoding='utf-8'?>
<document id="25456436"><sentence text="In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells."><entity charOffset="20-29" id="DDI-PubMed.25456436.s1.e0" text="berberine" /></sentence><sentence text="Berberine (BER) and BER-original herbal medicines have a variety of pharmacological functions and have been widely used in clinical"><entity charOffset="0-9" id="DDI-PubMed.25456436.s2.e0" text="Berberine" /><entity charOffset="11-14" id="DDI-PubMed.25456436.s2.e1" text="BER" /><entity charOffset="20-22" id="DDI-PubMed.25456436.s2.e2" text="BER" /><pair ddi="false" e1="DDI-PubMed.25456436.s2.e0" e2="DDI-PubMed.25456436.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25456436.s2.e0" e2="DDI-PubMed.25456436.s2.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s2.e0" e2="DDI-PubMed.25456436.s2.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s2.e1" e2="DDI-PubMed.25456436.s2.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s2.e1" e2="DDI-PubMed.25456436.s2.e2" /></sentence><sentence text=" However, its effect of enzyme induction on cytochrome P450 (CYP) in human hepatocytes is unknown" /><sentence text="" /><sentence text="Metabolism of berberine and its effect on main metabolic enzymes in HepG2 cell in vitro was investigated"><entity charOffset="14-23" id="DDI-PubMed.25456436.s5.e0" text="berberine" /></sentence><sentence text=" Cocktail probe drugs, mRNA expression and protein expression were used to evaluate the metabolism potency" /><sentence text=" Meanwhile, an UPLC-MS/MS method was validated for the analysis of BER and four probe drugs in HepG2 cell"><entity charOffset="67-75" id="DDI-PubMed.25456436.s7.e0" text="BER" /></sentence><sentence text="" /><sentence text="BER significantly increased the metabolism of midazolam, phenacetin and tolbutamide by inducing the CYP1A2 and 3A4 enzyme in a dose-dependent manner, the mRNA and protein expression of CYP1A2 and 3A4 were increased by berberine at 1000ng·mL(-1)"><entity charOffset="46-55" id="DDI-PubMed.25456436.s9.e0" text="midazolam" /><entity charOffset="57-67" id="DDI-PubMed.25456436.s9.e1" text="phenacetin" /><entity charOffset="72-83" id="DDI-PubMed.25456436.s9.e2" text="tolbutamide" /><entity charOffset="218-227" id="DDI-PubMed.25456436.s9.e3" text="berberine" /><entity charOffset="0-8" id="DDI-PubMed.25456436.s9.e4" text="BER" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e4" e2="DDI-PubMed.25456436.s9.e4" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e4" e2="DDI-PubMed.25456436.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e4" e2="DDI-PubMed.25456436.s9.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e4" e2="DDI-PubMed.25456436.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e4" e2="DDI-PubMed.25456436.s9.e3" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e0" e2="DDI-PubMed.25456436.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e0" e2="DDI-PubMed.25456436.s9.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e0" e2="DDI-PubMed.25456436.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e0" e2="DDI-PubMed.25456436.s9.e3" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e1" e2="DDI-PubMed.25456436.s9.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e1" e2="DDI-PubMed.25456436.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e1" e2="DDI-PubMed.25456436.s9.e3" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e2" e2="DDI-PubMed.25456436.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s9.e2" e2="DDI-PubMed.25456436.s9.e3" /></sentence><sentence text=" The activity of CYP1A2 and 3A4 could be induced by BER more than 500ng·mL(-1) in HepG2 cell, which was confirmed by the increase of its mRNA and protein expression"><entity charOffset="52-54" id="DDI-PubMed.25456436.s10.e0" text="BER" /></sentence><sentence text="" /><sentence text="BER increases the metabolism of cocktail drugs such as midazolam, phenacetin and tolbutamide by increasing the mRNA and protein expression of CYP1A2 and 3A4"><entity charOffset="55-64" id="DDI-PubMed.25456436.s12.e0" text="midazolam" /><entity charOffset="66-76" id="DDI-PubMed.25456436.s12.e1" text="phenacetin" /><entity charOffset="81-92" id="DDI-PubMed.25456436.s12.e2" text="tolbutamide" /><entity charOffset="0-10" id="DDI-PubMed.25456436.s12.e3" text="BER" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e3" e2="DDI-PubMed.25456436.s12.e3" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e3" e2="DDI-PubMed.25456436.s12.e0" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e3" e2="DDI-PubMed.25456436.s12.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e3" e2="DDI-PubMed.25456436.s12.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e0" e2="DDI-PubMed.25456436.s12.e0" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e0" e2="DDI-PubMed.25456436.s12.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e0" e2="DDI-PubMed.25456436.s12.e2" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e1" e2="DDI-PubMed.25456436.s12.e1" /><pair ddi="false" e1="DDI-PubMed.25456436.s12.e1" e2="DDI-PubMed.25456436.s12.e2" /></sentence><sentence text="" /></document>